EUROPEAN VASCULAR SURGERY TRADING LIMITED

EUROPEAN VASCULAR SURGERY TRADING LIMITED

EUROPEAN VASCULAR SURGERY TRADING LIMITED - Company Information

Print Friendly Version

EUROPEAN VASCULAR SURGERY TRADING LIMITED

Company Registration Number:
09481391 (England and Wales)

Unaudited abridged accounts for the year ended 31 December 2021

Period of accounts

Start date: 01 January 2021

End date: 31 December 2021

EUROPEAN VASCULAR SURGERY TRADING LIMITED

Contents of the Financial Statements

for the Period Ended 31 December 2021

Balance sheet
Notes

EUROPEAN VASCULAR SURGERY TRADING LIMITED

Balance sheet

As at 31 December 2021


Notes
2021
2020


£
£
Fixed assets
Investments: 3 1 1
Total fixed assets: 1 1
Current assets
Debtors:   206,954 144,596
Cash at bank and in hand: 94,812 30,071
Total current assets: 301,766 174,667
Creditors: amounts falling due within one year: 4 (301,766) (174,667)
Net current assets (liabilities): 0 0
Total assets less current liabilities: 1 1
Total net assets (liabilities): 1 1
Capital and reserves
Called up share capital: 1 1
Shareholders funds: 1 1

The notes form part of these financial statements

EUROPEAN VASCULAR SURGERY TRADING LIMITED

Balance sheet statements

For the year ending 31 December 2021 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with Section 444(2A).

These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

The directors have chosen to not file a copy of the company’s profit & loss account.

This report was approved by the board of directors on 27 June 2022
and signed on behalf of the board by:

Name: Dr Pirkka Vikatmaa
Status: Director

The notes form part of these financial statements

EUROPEAN VASCULAR SURGERY TRADING LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2021

1. Accounting policies

These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

Turnover policy

Turnover is recognised when it is receivable under the terms of the associated contract.

Valuation and information policy

Investments are included at fair value.

EUROPEAN VASCULAR SURGERY TRADING LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2021

2. Employees

2021 2020
Average number of employees during the period 0 0

EUROPEAN VASCULAR SURGERY TRADING LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2021

3. Fixed investments

Investment in subsidiary at 1 January and 31 December 2021: £1

EUROPEAN VASCULAR SURGERY TRADING LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2021

4. Creditors: amounts falling due within one year note

Other creditors: £6,713 (2020: £89,636)Amounts owed to group undertakings: £295,053 (2020: £138,289)Total: £301,766 (2020: £174,667)

EUROPEAN VASCULAR SURGERY TRADING LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2021

5. Related party transactions

The company's parent is European Society for Vascular Surgery, a charitable company registered in England and Wales with registered office at 18 Saxon Way, Romsey. Its principal place of business is 244 Boulevard Albert 1er, 33800 Bordeaux, France.